The Scottish Medicines Consortium has rejected donanemab for early Alzheimer’s disease, citing inadequate clinical and economic evidence. Medscape News UK Source link : https://www.medscape.com/viewarticle/alzheimer-antibody-therapy-denied-approval-scotland-2026a100045o?src=rss Author : Publish date : 2026-02-10...
Read more


















